KFDA to examine adverse reactions with Champix

The Korea Food and Drug Administration says that it instructed Pfizer Korea to include adverse reactions of its smoking cessation drug Champix to an insert paper.

Champix has been in the news a bit recently as there have been a number of reports saying that it can cause depression and even suicidal thoughts. In the United Kingdom the Medicines and Healthcare Products Regulatory Authority (MH...